SCHEMBL3938151

SCHEMBL3938151

Cc1cccc(N2CCC(NC(N)=O)C2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.60
MTNR1A P48039 1/20 0.52
MTNR1B P49286 1/20 0.52
NPY5R Q15761 1/20 0.50
RPS6KB1 P23443 1/20 0.48
SUV39H2 Q9H5I1 2/20 0.47
ACACB O00763 2/20 0.47
GPR119 Q8TDV5 1/20 0.46
GFER P55789 1/20 0.46
MDM4 O15151 2/20 0.44
DRD2 P14416 1/20 0.44
DRD3 P35462 1/20 0.44
FFAR4 Q5NUL3 1/20 0.44
SSTR1 P30872 1/20 0.43
SSTR4 P31391 1/20 0.43
NPC1 O15118 1/20 0.43
TP53 P04637 1/20 0.43
HPGD P15428 1/20 0.43
RAB9A P51151 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3938146 1.00 NOTUM (0.60) NOTUMMTNR1AMTNR1BNPY5RRPS6KB1
SCHEMBL6629804 0.92 NPY5R (0.57) NOTUMNPY5RRPS6KB1GPR119GFER
SCHEMBL19711007 0.88 NOTUM (0.61) NOTUMMTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL1350899 0.82 GPR119 (0.58) NOTUMMTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL1350901 0.82 GPR119 (0.58) NOTUMMTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL6559433 0.82 GPR119 (0.58) NOTUMMTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL3929593 0.80 USP30 (0.45) MTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL3929596 0.80 USP30 (0.45) MTNR1AMTNR1BNPY5RSUV39H2
SCHEMBL1350627 0.79 RECQL (0.54) NOTUMNPC1RAB9ASMN1; SMN2CA12
SCHEMBL1350625 0.79 RECQL (0.54) NOTUMNPC1RAB9ASMN1; SMN2CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425277-B8 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN GLAXO GROUP LTD (GB) 2009-04-01 EP claimed
EP-1425277-A2 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN SmithKline Beecham P.L.C. (GB) 2004-06-09 EP claimed
WO-2003022809-A2 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN SMITHKLINE BEECHAM P.L.C. (GB) 2003-03-20 WO claimed
EP-1425277-B8 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN GLAXO GROUP LTD (GB) 2009-04-01 EP disclosed
EP-1425277-A2 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN SmithKline Beecham P.L.C. (GB) 2004-06-09 EP disclosed
WO-2003022809-A2 UREA-COMPOUNDS ACTIVE AS VANILLOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF PAIN SMITHKLINE BEECHAM P.L.C. (GB) 2003-03-20 WO disclosed